Literature DB >> 18520999

Oxytocin receptor-deficient mice developed late-onset obesity.

Yuki Takayanagi1, Yoshiyuki Kasahara, Tatsushi Onaka, Nobuyuki Takahashi, Teruo Kawada, Katsuhiko Nishimori.   

Abstract

The oxytocin receptor has been suggested to be involved in energy metabolism, such as food intake and energy consumption. Here, we demonstrate that oxytocin receptor-deficient (Oxtr-/-) male mice exhibited late-onset obesity with increases in abdominal fat pads and fasting plasma triglycerides. Daily food intake and spontaneous motor activity of Oxtr-/- mice were not significantly different as compared with wild-type mice. In contrast, brown adipose tissue in Oxtr-/- mice contained large lipid droplets and cold-induced thermogenesis was impaired. This study demonstrates that oxytocin receptor plays essential roles in the regulation of energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520999     DOI: 10.1097/WNR.0b013e3283021ca9

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  108 in total

Review 1.  Using transgenic mouse models to study oxytocin's role in the facilitation of species propagation.

Authors:  Heon-Jin Lee; Jerome Pagani; W Scott Young
Journal:  Brain Res       Date:  2010-08-20       Impact factor: 3.252

Review 2.  Developmental specification of metabolic circuitry.

Authors:  Amanda E Elson; Richard B Simerly
Journal:  Front Neuroendocrinol       Date:  2015-09-25       Impact factor: 8.606

3.  Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats.

Authors:  Gregory J Morton; Brendan S Thatcher; Roger D Reidelberger; Kayoko Ogimoto; Tami Wolden-Hanson; Denis G Baskin; Michael W Schwartz; James E Blevins
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-18       Impact factor: 4.310

4.  Shedding heat on oxytocin.

Authors:  W Scott Young
Journal:  Endocrinology       Date:  2013-11       Impact factor: 4.736

5.  The hypothalamic neuropeptide oxytocin is required for formation of the neurovascular interface of the pituitary.

Authors:  Amos Gutnick; Janna Blechman; Jan Kaslin; Lukas Herwig; Heinz-Georg Belting; Markus Affolter; Joshua L Bonkowsky; Gil Levkowitz
Journal:  Dev Cell       Date:  2011-10-18       Impact factor: 12.270

Review 6.  Central nervous system regulation of brown adipose tissue.

Authors:  Shaun F Morrison; Christopher J Madden
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 7.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

Review 8.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

9.  Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

Authors:  Sara M Freeman; Julie Ngo; Bhavdeep Singh; Megan Masnaghetti; Karen L Bales; James E Blevins
Journal:  Neuroscience       Date:  2018-07-31       Impact factor: 3.590

10.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.